Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study

Fertility and Sterility

Volumn 89, Issue 3, 2008, Pages 685-692

  Moses Kolko, Eydie L ^a   Wisner, Katherine L ^a   Price, Julie C ^a   Berga, Sarah L ^b   Drevets, Wayne C ^a,c   Hanusa, Barbara H ^a   Loucks, Tammy L ^b   Meltzer, Carolyn C ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

5HT1A receptor; estradiol; PET; Postpartum depression; serotonin

Indexed keywords

CARBON 11; HORMONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; POSTSYNAPTIC RECEPTOR; SEROTONIN 1A RECEPTOR;

ARTICLE; BIPOLAR DEPRESSION; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; MAJOR DEPRESSION; MULTIVARIATE ANALYSIS OF VARIANCE; NEUROLOGIC DISEASE; PERINATAL PERIOD; POSITRON EMISSION TOMOGRAPHY; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PUERPERAL DEPRESSION; PUERPERIUM; SAMPLE (STATISTICS); SEROTONIN BRAIN LEVEL; TEMPORAL CORTEX;

ADULT; BRAIN CHEMISTRY; BREAST FEEDING; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; DEPRESSION, POSTPARTUM; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LIMBIC SYSTEM; LUTEINIZING HORMONE; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PROGESTERONE; PROLACTIN; PROTEIN BINDING; PSYCHIATRIC STATUS RATING SCALES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS; TIME FACTORS;

EID: 40249085826     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.03.059     Document Type: Article

References (60)

1. Gaynes B.N., Gavin N., Meltzer-Brody S., Lohr K.N., Swinson T., Gartlehner G., et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess 119 (2005) 1-18
2. Sit D. Women and bipolar disorder across the life span. J Am Med Womens Assoc 59 (2004) 91-100
3. Grace S.L., Evindar A., and Stewart D.E. The effect of postpartum depression on child cognitive development and behavior: a review and critical analysis of the literature. Arch Womens Ment Health 6 (2003) 263-274
4. Murray L. The impact of postnatal depression on infant development. J Child Psychol Psychiatry 33 (1992) 543-561
5. Goodman S.H., and Gotlib I.H. Risk for psychopathology in the children of depressed mothers: a developmental model for understanding mechanisms of transmission. Psychol Rev 106 (1999) 458-490
6. Misri S., Reebye P., Kendrick K., Carter D., Ryan D., Grunau R.E., et al. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. [see comment]. Am J Psychiatry 163 (2006) 1026-1032
7. Goodman J.H. Paternal postpartum depression, its relationship to maternal postpartum depression, and implications for family health. J Adv Nurs 45 (2004) 26-35
8. Cohen L.S., Viguera A.C., Bouffard S.M., Nonacs R.M., Morabito C., Collins M.H., et al. Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry 62 (2001) 592-596
9. Yonkers K., Wisner K., Stowe Z., Leibenluft E., Cohen L., Miller L., et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychol 161 (2004) 608-620
10. Wisner K.L., Hanusa B.H., Perel J.M., Peindl K.S., Piontek C.M., Sit D.K.Y., et al. Postpartum depression: a randomized trial of Sertraline vs. Nortriptyline. J Clin Psychopharmacol 26 (2006) 353-360
11. Scholle S.H., and Kelleher K.J. Assessing primary care among young, low-income women. Women Health 37 (2003) 15-30
12. Bloch M., Schmidt P., Danaceau M., Murphy J., Neiman L., and Rubinow D. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157 (2000) 924-930
13. Kornstein S.G., Schatzberg A.F., Thase M.E., Yonkers K.A., McCullough J.P., Keitner G.I., et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. [see comment]. Am J Psychiatry 157 (2000) 1445-1452
14. Wikander I., Sundblad C., Andersch B., Dagnell I., Zylberstein D., Bengtsson F., et al. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?. J Clin Psychopharmacol 18 (1998) 390-398
15. Freeman E.W., Rickels K., Sondheimer S.J., and Polansky M. Differerential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder. Arch Gen Psychiatry 56 (1999) 932-939
16. Bethea C.L., Lu N.Z., Gundlah C., and Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23 (2002) 41-100
17. Lopez J.F., Chalmers D.T., Little K.Y., and Watson S.J. Regulation of serotonin 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43 (1998) 547-573
18. Haddjeri N., Blier P., and De Montigny C. Long-term antidepressant treatments result in tonic activation of forebrain 5HT1A receptors. J Neurosci 18 (1998) 10150-10156
19. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Neurobiology 95 (1998) 14476-14481
20. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25 (2001) 892-903
21. Mann J.J., Malone K., Diehl D., Perel J., Cooper T., and Mintun M.A. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 153 (1996) 174-182
22. Bowen D.M., Najlerahim A., Procter A.W., Francis P.T., and Murphy E. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of late life. Proc Natl Acad Sci USA 86 (1989) 9504-9508
23. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46 (1999) 1375-1387
24. Meltzer C.C., Price J.C., Mathis C.A., Butters M.A., Ziolko S.K., Moses-Kolko E., et al. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 29 (2004) 2258-2265
25. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., et al. Brain serotonin 1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57 (2000) 174-180
26. Parsey R.V., Oquendo M.A., Ogden R.T., Olvet D.M., Simpson N., Huang Y., et al. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY 100635 positron emission tomography study. Biol Psychiatry 59 2 (2006) 106-113
27. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., and Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 18 (1998) 7394-7401
28. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (1998), New York State Psychiatric Institute, Biometrics Research Department, New York
29. American Psychiatric Association. American psychiatric association: diagnostic and statistical manual for psychiatric disorders, 4th edition, text revision (2000), American Psychiatric Association, Washington, DC
30. Stowe Z.N., Hostetter A.L., and Newport D.J. The onset of postpartum depression: implications for clinical screening in obstetrical and primary care. Am J Obstet Gynecol 192 (2005) 522-526
31. Blehar M.C., DePaulo Jr. J.R., Gershon E.S., Reich T., Simpson S.G., and Nurnberger Jr. J.I. Women with bipolar disorder: findings from the NIMH Genetics Initiative sample. Psychopharmacol Bull 34 (1998) 239-243
32. Viguera A., Nonacs R., Cohen L., Tondo L., Murray A., and Baldessarini R. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women. Am J Psychol 157 (2000) 179-184
33. Berga S.L., Daniels T.L., and Giles D.E. Women with functional hypothalamic amenorrhea but not other forms of anovulation display amplified cortisol concentrations. Fertil Steril 67 (1997) 1024-1030
34. McCarron J.A., Turton D., Pike V.W., and Poole K. Remotely controlled production of the 5HT1A receptor radioligand, [carbonyl-11C]WAY-100635, via 11C-carboxylation of an immobilized Grignard reagent. J Labelled Comp Radiopharm 38 (1996) 941-953
35. Moses-Kolko E., Meltzer C.C., Helsel J.C., Sheetz M., Mathis C., Ruszkiewicz J., et al. No interruption of lactation is needed after [11C]WAY 100635 or [11C]Raclopride PET. [letter]. J Nucl Med 46 (2005) 1765
36. Woods R.P., Mazziotta J.C., and Cherry S.R. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17 (1993) 536-546
37. Drevets W.C., Gadde K.M., and Krishnan K.R.R. The neurobiological foundation of mental illness. In: Charney D., and Nestler E. (Eds). Neurobiology of mental illness (2004), Oxford Press, Oxford, United Kingdom Chapter 32
38. Arango V., Underwood M.D., Gubbi A.V., and Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688 (1995) 121-133
39. Parsey R.V., Arango V., Olvet D.M., Oquendo M.A., Van Heertum R.L., and Mann J.J. Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. J Cereb Blood Flow Metab 25 (2005) 785-793
40. Meltzer C.C., Drevets W.C., Price J.C., Mathis C.A., Lopresti B., Greer P.J., et al. Gender-specific aging effects on the serotonin 1A receptor. Brain Res 895 (2001) 9-17
41. Price J.C., Kelley D.E., Ryan C.M., Meltzer C.C., Drevets W.C., Mathis C.A., et al. Evidence of increased serotonin-1A receptor binding in type 2 diabetes: a positron emission tomography study. Brain Res 927 (2002) 97-103
42. Bailer U.F., Frank G.K., Henry S.E., Price J.C., Meltzer C.C., Weissfeld L., et al. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measures by positron emission tomography and [11C]WAY 100635. Arch Gen Psychiatry 62 (2005) 1032-1041
43. Logan J., Fowler J.S., Volkow N.D., Ding Y.S., Wang G.J., and Alexoff D.L. A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab 21 (2001) 307-320
44. Price J.C., Xu L., Mazumdar S., Meltzer C.C., Drevets W.C., Mathis C.A., et al. Impact of graphical analysis analysis bias on group comparisons of regional [carbonyl-11C]WAY binding potential measures. Neuroimage 16 3 (2002) S72
45. Lammertsma A., Bench C., Hume S., Osman S., Gunn K., Brooks D.J., et al. Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 16 (1996) 42-52
46. Mintun M.A., Raichle M.E., Kilbourn M.R., Wooten G.F., and Welch M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15 (1984) 217-227
47. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
48. Sheline Y.I. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 48 (2000) 791-800
49. Meltzer C.C., Leal J.P., Mayberg H.S., Wagner H.J., and Frost J.J. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr 14 (1990) 561-570
50. Meltzer C., Kinahan P., Nichols T., Greer P., Comtat C., Cantwell M., et al. Comparative evaluation of MR-based partial volume correction schemes for PET. J Nucl Med 40 (1999) 2053-2065
51. Battin D.A., Marrs R.P., Fleiss P.M., and Mishell Jr. D.R. Effect of suckling on serum prolactin, luteinizing hormone, follicle-stimulating hormone, and estradiol during prolonged lactation. Obstet Gynecol 65 (1985) 785-788
52. Azmitia E.C., Gannon P.J., Kheck N.M., and Whitaker-Azmitia P.M. Cellular localization of the 5HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 14 (1996) 35-46
53. Azmitia E.C. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. [abstract]. Neuropsychopharmacology 21 (1999) 2S
54. Bhagwagar Z., Rabiner E.A., Sargent P.A., Grasby P.M., and Cowen P.J. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9 (2004) 386-392
55. Mastorakos G., and Ilias I. Maternal hypothalamic-pituitary-adrenal axis in pregnancy and the postpartum period. Ann NY Acad Sci 900 (2000) 95-106
56. Altemus M., Deuster P., Galliven E., Carter S., and Gold P.W. Suppression of hypothalamic-pituitary-adrenal axis responses to stress in lactating women. J Clin Endocrinol Metab 80 (1995) 2954-2959
57. Neumann I.D., Torner L., and Wigger A. Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience 95 (2000) 567-575
58. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23 (2003) 8788-8799
59. Cox J., Holden J., and Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150 (1987) 782-786
60. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62